Daclizumab and haemoglobin decreased Patient Reports February 12, 2012

Daclizumab Side Effects Report #5473223-0
Daclizumab side effect was reported by a Physician from UNITED STATES on Sept 21, 2007. Female patient, 33 years of age, weighting 164.2 lb, was diagnosed with multiple sclerosis  and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: adrenal insufficiency, adrenal suppression, eyelid oedema, haemoglobin decreased, hyperhidrosis, hyponatraemia, hypopituitarism, multiple sclerosis relapse, white blood cell count decreased. Daclizumab dosage: unknown. During the same period patient was treated with BACLOFEN, TRIPHASIL, IBUPROFEN, ACETAMINOPHEN, REBIF, KALCIUM D, VITAMIN B CAP. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #5110086-7
Daclizumab side effect was reported by a Health Professional from UNITED STATES on Sept 19, 2006. Female patient, 45 years of age, weighting 149.7 lb, was diagnosed with intermediate uveitis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: dyspnoea exertional, fatigue, haemoglobin decreased, malaise. Daclizumab dosage: 2 MG/KG PER DOSE EVERY 4 WEEKS. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4636372-2
Daclizumab side effect was reported by a Physician from on Jan 18, 2005. Female patient, child 7 years of age, weighting 59.08 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: abdominal pain , blood urea increased, cerebral ventricle dilatation, diarrhoea, encephalitis , encephalitis viral, haemoglobin decreased, hydrocephalus , oligodipsia. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PROGRAF, PREDNISONE, VALGANCICLOVIR, SEPTRA, ASPIRIN, PRILOSEC, MAGNESIUM PLUS PROTEIN. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4592843-9
Daclizumab side effect was reported by a Physician from on Jan 04, 2005. Female patient, 45 years of age, weighting 163.1 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: haemodialysis, haemoglobin decreased, renal failure acute, retroperitoneal haematoma, shock haemorrhagic, thrombotic microangiopathy. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, BACTRIM, STEROIDS NOS, CORTANCYL, ZANTAC, AUGMENTIN. Patient recovered.


Daclizumab Side Effects Report #4674531-3
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites infection, escherichia infection, gastrointestinal haemorrhage, haematemesis, haemoglobin decreased, pleural effusion, renal impairment, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4683900-7
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites infection, blood albumin decreased, enterococcal infection, escherichia infection, gastrointestinal haemorrhage, haemoglobin decreased, laceration, oedema peripheral, pleural effusion. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4706625-8
Daclizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: abdominal sepsis, ascites infection, atrial fibrillation , blood albumin decreased, enterococcal infection, escherichia infection, gastrointestinal haemorrhage, haemoglobin decreased, multi-organ failure. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient died on 06/14/2005.